The effect of genetic variation in angiotensinogen on serum levels and blood pressure: A comparison of Nigerians and US blacks

Journal of Human Hypertension

Volumn 20, Issue 11, 2006, Pages 882-887

  Fejerman, L ^a   Wu, X ^b   Adeyemo, A ^c   Luke, A ^b   Zhu, X ^b   Hicks, C ^b   Cooper, R S ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN;

ADULT; AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FAMILY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEGRO; PATHOGENESIS; PHENOTYPE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; ANGIOTENSINOGEN; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CHICAGO; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NIGERIA; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS;

EID: 33750337286     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002077     Document Type: Article

References (37)

1. Cusi D, Macciardi F, Barlassina C. Angiotensinogen gene polymorphism, again? J Hypertens 2003; 21(10): 1815-1818.
2. Zhu X, Bouzerkri N, Southam L, Cooper RS, Adeyemo A, Mckenzie CA et al. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 2001; 68(5): 1139-1148.
3. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992; 71(1): 169-180.
4. Iso H, Harada S, Shimamot T, Sato S, Kitamura A, Sankai T et al. Angiotensinogen T174M and M235T variants, sodium intake and hypertension among non-drinking, lean Japanese men and women. J Hypertens 2000; 18(9): 1197-1206.
5. Sato N, Katsuya T, Nakagawa T, Ishikawa K, Fu Y, Asai T et al. Nine polymorphisms of angiotensinogen gene in the susceptibility to essential hypertension. Life Sci 2000; 68(3): 259-272.
6. Sethi AA, Nordestgaard BG, Agerholm-Larsen B, Frandsen E, Jensen G, Tybjaerg-Hansen A. Angiotensinogen polymorphisms and elevated blood pressure in the general population: The Copenhagen City Heart Study. Hypertension 2001; 37(3): 875-881.
7. Svetkey LP, Moore TJ, Simons-Morton DG, Appel LJ, Bray GA, Sacks FM et al. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens 2001; 19(11): 1949-1956.
8. Pereira AC, Mota GFA, Cunha RS, Herbenhoff FL, Mill JG, Krieger JE et al. Angiotensinogen 235T allele dosage is associated with blood pressure phenotype. Hypertension 2003; 41: 25-30.
9. Bengtsson K, Orho-Melander M, Lindbland U, Melander O, Bog-Hansen E, Ranstam L et al. Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: The Skaraborg Hypertension and diabetes project. J Hypertens 1999; 17(11): 1569-1575.
10. Niu T, Chen C, Yang J, Wang B, Wang Z, Schork N et al. Blood pressure and the T174M and M235T polymorphisms of the angiotensinogen gene. Ann Epidemiol 1999; 9(4): 245-253.
11. Taittonen L, Uhari M, Kontula K, Kainulainen K, Miettinen H, Turtinen J et al. Angiotensin converting enzyme gene insertion/deletion polymorphism, angiotensinogen gene polymorphisms, family history of hypertension, and childhood blood pressure. American Journal of Hypertension. J Am Soc Hypertens 1999; 12(9 Part 1): 858-866.
12. Kato N, Sugiyama T, Morita H, Kurihara H, Furukawa T, Isshiki T et al. Comprehensive analysis of the rennin-angiotensin gene polymorphisms with relation to hypertension in the Japanese. J Hypertens 2000; 18(8): 1025-1032.
13. Larson N, Hutchinson R, Boerwinkle E. Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension 2000; 35(6): 1297-1300.
14. Province MA, Boerwinkle E, Chakravarti A, Cooper R, Fornage M, Leppert M et al. Lack of association of the angiotensinogen-6 polymorphism with blood pressure levels in the comprehensive NHLBI family blood pressure program. National Heart, Lung and Blood Institute. J Hypertens 2000; 18(7): 867-876.
15. Fejerman L, Bouzekri N, Wu X, Adeyemo A, Luke A, Zhu X et al. Association between evolutionary history of angiotensinogen haplotypes and plasma levels. Hum Genet 2004; 115(5): 310-318.
16. Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: Linked loci and correlated allele frequencies. Genetics 2003; 164: 1567-1587.
17. Ataman SL, Cooper RS, Rotimi CN, McGee D, Osotimehin B, Kadiri S et al. Standardization of blood pressure measurement in an international collaborative study. J Clin Epidemiol 1996; 49: 869-877.
18. Cooper RS, Rotimi CN, Ataman SL, McGee D, Osotimehin B, Kadiri S et al. The prevalence of hypertension in seven populations of West African origin. Am J Public Health 1997; 87: 160-168.
19. Rotimi C, Cooper R, Ogunbiyi O, Morrison L, Ladipo M, Tewksbury D et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation 1997; 95(10): 2348-2350.
20. Plummer S, Morgan L, Kalsheker N. SNPs at the 3′ end of the angiotensinogen gene define two haplotypes associated with the common 235Met variant. Am J Hum Genet 2002; 71: 443-444.
21. SAS Version 8.2. SAS Institute: Cary, NC.
22. Almasy L, Blangero J. Multipoint quantitative-trait analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198-1211.
23. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30(1): 97-101.
24. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 2001; 9: 301-306.
25. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM. Family-based test for associating haplotypes with general phenotype data: Application to asthma genetics. Genet Epidemiol 2004; 26: 61-69.
26. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74(4): 765-769.
27. Nakajima T, Wooding S, Sakagami T, Emi M, Tokunaga K, Tamiya G et al. Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet 2004; 74(5): 898-916.
28. Sethi AA, Nordestgaard BG, Gronholdt ML, Steffensen R, Jensen G, Tybjaerg-Hansen A. Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension 2003; 41: 1202-1211.
29. Wu X, Luke A, Rieder M, Lee K, Toth EJ, Nickerson D et al. An association study of angiotensinogen polymorphisms with serum level and hypertension in an African-American population. J Hypertens 2003; 21: 1847-1852.
30. Poston WS, Pavlik VN, Hyman DJ, Ogbonnaya K, Hanis CL, Haddock CK et al. Genetic bottlenecks, perceived racism, and hypertension risk among African Americans and first-generation African immigrants. J Hum Hypertens 2001; 15(5): 341-351.
31. Rotimi C, Morrison L, Cooper R, Oyejide C, Effiong E, Ladipo M et al. Angiotensinogen gene in human hypertension: Lack of an association of the 235T allele among African Americans. Hypertension 1994; 24: 591-594.
32. Kumar A, Li Y, Patil S, Jain S. A haplotype of the angiotensinogen gene is associated with hypertension in African Americans. Clin Exp Pharmacol Physiol 2005; 32(5-6): 495-502.
33. Markovic D, Tang X, Guruju M, Levenstien MA, Hoh J, Kumar A et al. Association of angiotensinogen gene polymorphisms with essential hypertension in African Americans and Caucasians. Hum Hered 2005; 60(2): 89-96.
34. Jain S, Tang X, Narayanan CS, Agarwal Y, Peterson SM, Brown CD et al. Angiotensinogen gene polymorphism at - 217 affects basal promoter activity and is associated with hypertension in African-Americans. J Biol Chem 2002; 277(39): 36889-36896.
35. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99(7): 1786-1797.
36. Yanai K, Nibu Y, Murakami K, Fukamizu A. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene. J Biol Chem 1996; 271(27): 15981-15986.
37. Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moison P et al. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med 1995; 1(10): 1009-1016.